Clinical observation of Cinacalcet in the treatment of secondary hyperparathyroidism in hemodialysis patients
Objective To discuss the clinical effects of Cinacalcet--a calcium sensitive receptor agonist in maintenance hemodialysis(MDH)patients with secondary hyperparathyroidism(SHPT).Methods Ninety-eight MDH patients with SHPT admitted at the Fifth Hospital of Wuhan were divided into the observation group(...
Saved in:
| Main Authors: | ZHANG Xin, ZHOU Huan, WANG Xiao-hui, HE Yong, PENG Qing-ping |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2018-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57915895&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Observation of low dosage of cinacalcet combined with calcitriol injection for the treatment of refractory secondary hyperparathyroidism in hemodialysis patients
by: GUO Jun-li, et al.
Published: (2020-01-01) -
Effectiveness and safety of activated vitamin D combined with cinacalcet in the treatment of secondary hyperparathyroidism in hemodialysis patients
by: WANG Yun
Published: (2018-01-01) -
Preliminary exploration of the role of parathyroid volume in predicting the efficacy of cinacalcet on secondary hyperparathyroidism
by: TANG Li, et al.
Published: (2020-01-01) -
Meta-analysis of cinacalcet plus calcitriol for the treatment of secondary hyperparathyroidism in hemodialysis patients
by: Feng Hui-ling, et al.
Published: (2022-06-01) -
A Meta-analysis of Cinacalcet in the treatment of dialysis patients with secondary hyperparathyroidism
by: LV Yuan, et al.
Published: (2018-01-01)